Boston, MA -- (SBWIRE) -- 12/13/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: JPMorgan Chase & Co. (NYSE:JPM), Molycorp Inc (NYSE:MCP), Glu Mobile Inc. (NASDAQ:GLUU), Cellceutix Corp (OTCMKTS:CTIX).
JPMorgan Chase & Co. (NYSE:JPM), opened its shares at the price of $56.05 for the day. Its closing price was $56.31 after gaining0.43% for the day. The company traded with the total volume of 15.33 million shares, while its average trading volume remained 18.14 million shares. The beta of JPM stands at1.68.
JPMorgan Chase & Co., a financial holding company, provides various financial services worldwide
Will JPM Continue To Move Higher? Find Out Here
Molycorp Inc (NYSE:MCP), percentage change plunged -2.74% to close at $4.61 with the total traded volume of 4.31 million shares, and average volume of 5.63 million. The 52 week range of the stock remained $4.51 - $11.81, while its day lowest price was $4.59and it hit its day highest price at $4.74.
Molycorp, Inc. produces and sells rare earth and rare metal materials in the United States and internationally.
-Will MCP Get Buyers Even After The Recent Rally? Find Out Here
Glu Mobile Inc. (NASDAQ:GLUU), started its trading session with the price of $3.47 and closed at $3.44 by scoring –0.58%. GLUU’s stocks traded with total volume of 1.73 million shares, while the average trading volume remained 2.90 million shares. The beta of GLUU stands at 1.70. Day range of the stock was $3.40 -$3.50.
Glu Mobile Inc. develops and publishes a portfolio of action/adventure and casual games for the users of smartphones and tablet devices.
-Will GLUU Get Buyers Even After The Recent Rally? Find Out Here
Cellceutix Corp (OTCMKTS:CTIX) ended its day with the gain of 4.60% and closed at the price of $1.82 after opening at $1.77. Stock traded during its last trading session with the total volume of 253,768 shares, as compared to its average volume of 166,561 shares.
Cellceutix Corporation, a development stage biopharmaceutical company, engages in the discovery and development of small molecule drugs to treat diseases primarily in the areas of cancer and inflammatory disease
Will CTIX Continue To Move Higher? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)